Infant Resuscitators Market Size to Surge USD 533.97 Million by 2035

Key Takeaways

• North America led the market with the largest share in 2025.
• Asia Pacific is expected to grow at the fastest CAGR during the forecast period.
• By product type, the self-inflating bag-valve masks segment held the largest share of the market in 2025.
• By product type, the automated / mechanical resuscitator segment is expected to expand at a significant CAGR during the forecast period.
• By modality, the disposable segment held the largest share of the market in 2025.
• By modality, the reusable segment is expected to grow with a robust CAGR between 2026 and 2035.
• By technology, the pressure-limited segment held the highest share of the market in 2025.
• By technology, the PEEP-capable segment is expected to grow with a considerable CAGR during the forecast period.
• By end user, the hospitals & NICUs segment dominated the market in 2025.
• By end user, the ambulatory surgical centers segment is expected to rise with a notable CAGR during the forecast period.

Market Overview

The infant resuscitators market encompasses the development, manufacturing, and distribution of specialized medical devices designed to provide emergency respiratory support to newborns (neonates) who are unable to breathe independently or exhibit low heart rates immediately after birth. These devices deliver positive pressure ventilation through a face mask or endotracheal tube to help inflate immature lungs and stabilize vital functions.

Rising incidences of neonatal asphyxia remain a primary growth driver for the market. According to global health reports, birth asphyxia continues to be a significant contributor to neonatal mortality, particularly in low- and middle-income countries. Increasing awareness among healthcare providers and growing initiatives by international organizations to reduce neonatal mortality rates are further strengthening demand for advanced resuscitation solutions.

The expanding global medical devices industry, improvements in hospital infrastructure, and rising investments in maternal and child healthcare are expected to support sustained market growth over the forecast period.

Infant Resuscitators Market Trends

• Strategic Partnerships: Medical device manufacturers are collaborating with technology providers to develop next-generation smart resuscitators that enhance precision, monitoring, and neonatal care outcomes.
• Rising Neonatal Mortality in Developing Nations: Increasing neonatal deaths in countries such as Pakistan, Afghanistan, Chad, Mali, Somalia, and South Sudan are driving demand for reliable and advanced resuscitation equipment in hospitals and community healthcare centers.
• Government-Led Initiatives: Governments across multiple regions are introducing national neonatal health programs, funding maternal healthcare services, and strengthening newborn care policies to reduce infant mortality rates.
• Joint Investments and Funding Activities: Cross-border investments and funding collaborations are supporting product innovation, manufacturing expansion, and improved access to neonatal resuscitation devices.
• Shift Toward Portable and Compact Devices: There is growing demand for lightweight, portable infant resuscitators suitable for ambulances, remote clinics, rural healthcare settings, and inter-hospital transport, enhancing accessibility in emergency situations.
• Business Expansion Strategies: Leading market players are expanding production capacities and establishing new manufacturing facilities to meet rising global demand and diversify product portfolios.

Role of Artificial Intelligence in the Infant Resuscitators Industry

Artificial Intelligence (AI) is increasingly transforming the infant resuscitators industry by improving clinical decision-making, monitoring accuracy, and training effectiveness. AI-powered solutions enable real-time data analysis and monitoring of neonatal vital parameters, providing healthcare professionals with actionable insights during critical resuscitation procedures.

Predictive analytics tools assist in the early detection of potential complications, allowing clinicians to tailor care strategies for individual infants. AI systems can also deliver precise feedback on cardiopulmonary resuscitation (CPR) techniques, enhancing procedural accuracy and improving survival outcomes.

In addition to clinical applications, AI-driven simulators are enhancing medical training by offering interactive, realistic, and personalized learning environments. These simulation systems improve healthcare provider preparedness and skill development, ensuring higher standards of neonatal emergency response.

In April 2025, AngelEye Health launched AIVision, an advanced platform designed to transform neonatal intensive care units (NICUs) through the integration of AI and computer vision technologies. The platform enhances patient monitoring, supports clinical workflows, and contributes to improved neonatal care delivery.

Regional Insights

North America holds a substantial share of the infant resuscitators market, supported by strong healthcare infrastructure, high neonatal care standards, and significant investments in medical technology adoption. The United States and Canada are key contributors, driven by rising demand for advanced neonatal care solutions, increased hospital spending on emergency care units, and continuous innovation by domestic medical device manufacturers. Well-established reimbursement frameworks and strict quality standards also encourage adoption of smart resuscitation devices. Additionally, clinical training programs and neonatal safety initiatives across hospitals and medical institutions contribute to market growth.

Europe represents a mature market for infant resuscitators, with strong demand from both public and private healthcare sectors. Countries such as Germany, the United Kingdom, and France lead in neonatal care expenditure and advanced medical device uptake. Focused government policies aimed at improving maternal and newborn health, along with high awareness among healthcare professionals, are supporting growth. Moreover, Europe’s stringent regulatory environment ensures quality and safety, fostering the adoption of next-generation resuscitation systems. Collaborative research and inclusion of resuscitator training in medical curricula further expand market penetration across the region.

The Asia Pacific region is projected to register robust growth in the infant resuscitators market due to improving healthcare infrastructure, rising neonatal mortality concerns in several developing countries, and expanding access to quality medical care. China, India, Japan, and South Korea are witnessing increased investments in neonatal intensive care solutions. Growing awareness among clinicians about early intervention and government initiatives to strengthen maternal and newborn healthcare systems are significant drivers. Additionally, the expanding presence of global and regional medical device manufacturers is enhancing product availability and distribution in tier-2 and tier-3 cities.

Infant Resuscitators Market Key Players

• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Ambu A/S
• Teleflex Incorporated
• Vyaire Medical Inc.
• Intersurgical Ltd
• ICU Medical
• Laerdal Medical AS
• Medline Industries LP
• Mercury Medical
• Nihon Kohden Corporation
• Atom Medical Corporation
• Besmed Health Business Corp.
• SunMed LLC
• Allied Healthcare Products Inc.
• Pennine Healthcare